Used in research as a potent inhibitor of cyclin-dependent kinases (CDKs) and Aurora kinases, which are key regulators of the cell cycle. This compound is primarily utilized in preclinical studies to investigate cancer cell proliferation and apoptosis. It shows potential in suppressing tumor growth by inducing cell cycle arrest, particularly in G1 and G2/M phases. Due to its dual inhibitory activity, it serves as a valuable tool for studying signaling pathways involved in oncology and for developing targeted cancer therapies. Its application remains confined to laboratory and experimental settings, with no current clinical use in humans.